Literature DB >> 22419255

Tumour immunology: dendritic cell switch.

Sarah Seton-Rogers.   

Abstract

Year:  2012        PMID： 22419255     DOI： 10.1038/nrc3253

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  1 in total

1.  Ovarian cancer progression is controlled by phenotypic changes in dendritic cells.

Authors:  Uciane K Scarlett; Melanie R Rutkowski; Adam M Rauwerdink; Jennifer Fields; Ximena Escovar-Fadul; Jason Baird; Juan R Cubillos-Ruiz; Ana C Jacobs; Jorge L Gonzalez; John Weaver; Steven Fiering; Jose R Conejo-Garcia
Journal:  J Exp Med       Date:  2012-02-20       Impact factor: 14.307
  1 in total
  2 in total

1.  Blockade of MIF-CD74 Signalling on Macrophages and Dendritic Cells Restores the Antitumour Immune Response Against Metastatic Melanoma.

Authors:  Carlos R Figueiredo; Ricardo A Azevedo; Sasha Mousdell; Pedro T Resende-Lara; Lucy Ireland; Almudena Santos; Natalia Girola; Rodrigo L O R Cunha; Michael C Schmid; Luciano Polonelli; Luiz R Travassos; Ainhoa Mielgo
Journal:  Front Immunol       Date:  2018-05-23       Impact factor: 7.561

2.  Tumour microenvironment of both early- and late-stage colorectal cancer is equally immunosuppressive.

Authors:  A O'Toole; A J Michielsen; B Nolan; M Tosetto; K Sheahan; H E Mulcahy; D C Winter; J M Hyland; P R O'Connell; D Fennelly; D O'Donoghue; J O'Sullivan; G A Doherty; E J Ryan
Journal:  Br J Cancer       Date:  2014-07-24       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.